Answers are grounded in this paper and cite their sources.
OBJECTIVE: Early recognition of drug-resistant epilepsy (DRE) is critical for timely referral to comprehensive epilepsy centers (CECs). Our prior pilot study in the Veterans Health Administration (VHA) demonstrated the feasibility of an algorithm-based approach to identify DRE within selected CECs. In this study, we validated and refined these algorithms in a broader, national cohort, including CEC and non-CEC care, to optimize algorithms for different care settings. METHODS: We conducted a multicenter, retrospective study of randomly sampled veterans with epilepsy on ≥2 antiseizure medications (ASMs) from 1999 to 2024. Chart review by 26 epilepsy providers rated DRE status. Ninety-six candidate algorithms using combinations of six criteria-number of ASMs, treatment duration, dose thresholds, pregabalin exclusion, intractable International Classification of Diseases (ICD) codes, and electroencephalography (EEG)/magnetic resonance imaging (MRI) utilization-were evaluated. Performance for DRE classification was evaluated among all veterans, and separately for CEC or non-CEC care. RESULTS: Among 970 veterans on ≥2 lifetime ASMs, 518 (53.4%) were rated as DRE, 363 (37.4%) as non-DRE, and 89 (9.2%) as undetermined. Veterans with DRE were younger (mean age = 68.9 vs. 72.0 years) and more frequently had at least one intractable ICD code (46.1% vs. 18.2%), EEG (77.8% vs. 66.7%), or MRI (78.0% vs. 65.8%) compared with non-DRE (all p-values <.001). Among all veterans, the best overall algorithm (area under the curve [AUC] = .701) identified DRE as either (1) exposure to 3+ ASMs or (2) exposure to two ASMs for at least 1 year, with the requirement of past EEG/MRI and intractable ICD code documentation. This algorithm was also highly effective among veterans who received CEC (AUC = .756) or only non-CEC care (AUC = .678). SIGNIFICANCE: This national validation study confirms that medication-based algorithms can identify DRE within VHA administrative data across care settings (CECs and non-CECs). This supports the implementation of a standardized DRE definition for quality improvement, surveillance, and referral optimization within the VHA.
No takes yet. Share an insight, caveat, or question.
Haneef et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: